Cytosorbents Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.787201 million compared to USD 0.111867 million a year ago. Revenue was USD 34.69 million compared to USD 43.17 million a year ago.

Net loss was USD 32.81 million compared to USD 24.56 million a year ago. Basic loss per share from continuing operations was USD 0.75 compared to USD 0.57 a year ago. Diluted loss per share from continuing operations was USD 0.75 compared to USD 0.57 a year ago.